No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Benzenesulfonates / adverse effects
-
Benzenesulfonates / therapeutic use
-
Benzoquinones / adverse effects
-
Benzoquinones / therapeutic use
-
Disease Progression
-
Dose-Response Relationship, Drug
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Humans
-
Imatinib Mesylate
-
Indoles / adverse effects
-
Indoles / therapeutic use
-
Lactams, Macrocyclic / adverse effects
-
Lactams, Macrocyclic / therapeutic use
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Pyridines / adverse effects
-
Pyridines / therapeutic use
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use
-
Pyrroles / adverse effects
-
Pyrroles / therapeutic use
-
Sorafenib
-
Sunitinib
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Benzenesulfonates
-
Benzoquinones
-
Indoles
-
Lactams, Macrocyclic
-
Phenylurea Compounds
-
Piperazines
-
Pyridines
-
Pyrimidines
-
Pyrroles
-
Niacinamide
-
tanespimycin
-
Imatinib Mesylate
-
Sorafenib
-
nilotinib
-
Sunitinib